Pharsight Achieves 8 Percent Revenue Growth for First Quarter
24 juil. 2008 16h07 HE
|
Pharsight Corporation
Reporting and Analysis Services Business Unit Grows
278 Percent Over Prior Year
Company Reiterates Fiscal 2009 Guidance
MOUNTAIN VIEW, Calif., July 24, 2008...
Pharsight and CRI Worldwide Establish Alliance
22 juil. 2008 06h40 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., and CLEMENTON, N.J., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for...
Pharsight to Present On Modeling and Simulation At Quebec CPT World Congress
22 juil. 2008 06h30 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
Pharsight Broadens Reporting and Analysis Services Offerings
15 juil. 2008 06h30 HE
|
Pharsight Corporation
New Offerings Include Preclinical, Biostatistics, Data Management
Company Expands RAS Management Team
MOUNTAIN VIEW, Calif., July 15, 2008 (PRIME NEWSWIRE) -- Pharsight...
Pharsight Announces Fiscal First Quarter 2009 Earnings Release Date and Conference Call
10 juil. 2008 16h05 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 10, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
Pharsight to Present At Controlled Release Society Conference
10 juil. 2008 06h30 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 10, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
Pharsight Added to Russell Microcap Index
01 juil. 2008 16h05 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 1, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software and strategic services designed to optimize clinical drug development,...